Trident Lifeline Limited (BOM:543616)

India · Delayed Price · Currency is INR

258.80

+13.50 (5.50%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Sale of Pharmaceuticals Products	869.65M	446.29M	316.92M	217.68M
Sale of Pharmaceuticals Products Growth	94.86%	40.82%	45.59%	-
Total	869.65M	446.29M	316.92M	217.68M
Total Growth	94.86%	40.82%	45.59%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	220.66M	216.64M	149.26M	52.43M
India Growth	1.85%	45.15%	184.66%	-
Ghana	85.63M	110.64M	108.35M	101.59M
Ghana Growth	-22.61%	2.12%	6.65%	-
Kenya	70.64M	40.07M	7.66M	11.13M
Kenya Growth	76.30%	423.34%	-31.18%	-
Peru	65.39M	22.71M	-	-
Peru Growth	187.89%	-	-	-
Cameroon	3.08M	-	8.29M	14.00M
Cameroon Growth	-	-	-40.75%	-
Venezuela	221.29M	52.19M	29.67M	18.79M
Venezuela Growth	324.01%	75.92%	57.88%	-
Rest of World	12.19M	4.27M	13.70M	9.17M
Rest of World Growth	185.39%	-68.84%	49.41%	-
Nigeria	-	-	-	10.57M
Total	678.85M	446.52M	316.92M	217.68M
Total Growth	52.03%	40.89%	45.59%	-

Source: S&P Global Market Intelligence.